ArticleBMC urology2025

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil.

Juan Manuel Palacios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.